These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10440909

  • 1. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease.
    Saito Y, Wada H, Yamamuro M, Inoue A, Shimura M, Hiyoyama K, Gabazza EC, Isaka N, Shiku H, Takeya H, Suzuki K, Kumeda K, Kato H, Nakano T.
    Am J Hematol; 1999 Aug; 61(4):238-42. PubMed ID: 10440909
    [Abstract] [Full Text] [Related]

  • 2. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
    Kamikura Y, Wada H, Yamada A, Shimura M, Hiyoyama K, Shiku H, Tanigawa M, Nishikawa H, Yamada N, Isaka N, Nakano T, Kumeda K, Kato H.
    Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877
    [Abstract] [Full Text] [Related]

  • 3. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
    Inoue A, Wada H, Takagi M, Yamamuro M, Mukai K, Nakasaki T, Shimura M, Hiyoyama K, Deguchi H, Gabazza EC, Mori Y, Nishikawa M, Deguchi K, Shiku H.
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
    [Abstract] [Full Text] [Related]

  • 4. Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary angioplasty.
    Mizuno O, Ikeda U, Hojo Y, Fujikawa H, Katsuki T, Shimada K.
    Cardiology; 2001 Apr; 95(2):84-9. PubMed ID: 11423712
    [Abstract] [Full Text] [Related]

  • 5. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M, Nakabayashi T, Iuchi K, Ishikawa T, Kaseno K, Yoshida T, Asakura H, Matsuda T.
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
    Alaigh P, Hoffman CJ, Korlipara G, Neuroth A, Dervan JP, Lawson WE, Hultin MB.
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
    [Abstract] [Full Text] [Related]

  • 7. Absence of a prothrombotic state in restenotic patients?
    Brack MJ, More RS, Pringle S, Gershlick AH.
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [Abstract] [Full Text] [Related]

  • 8. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K, Miura F, Sugino H, Shinobe M, Shirotani M, Yoshida H, Mori N, Hoshino T, Takada A.
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [Abstract] [Full Text] [Related]

  • 9. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease.
    Kim HK, Song KS, Park YS, Yun YS, Shim WH.
    Cardiology; 2000 Jan; 93(1-2):31-6. PubMed ID: 10894904
    [Abstract] [Full Text] [Related]

  • 10. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S, Tukada T, Nakanishi S, Nishiyama S, Seki A.
    Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
    [Abstract] [Full Text] [Related]

  • 11. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Tanigawa M, Wada H, Minamikawa K, Wakita Y, Nagaya S, Mori T, Tamaki S, Nishikawa H, Kakuta Y, Nakano T.
    Am J Hematol; 1995 May; 49(1):1-5. PubMed ID: 7741129
    [Abstract] [Full Text] [Related]

  • 12. Assessment of coagulation and platelet activation in coronary sinus blood induced by transcatheter coronary intervention for narrowing of the left anterior descending coronary artery.
    Mizuno O, Hojo Y, Ikeda U, Katsuki T, Fukazawa H, Kurosaki K, Fujikawa H, Shimada K.
    Am J Cardiol; 2000 Jan 15; 85(2):154-60. PubMed ID: 10955369
    [Abstract] [Full Text] [Related]

  • 13. Aberrations of the tissue factor pathway in patients positive for lupus anticoagulant.
    Wakita Y, Wada H, Nakase T, Nakasaki T, Shimura M, Hiyoyama K, Mori Y, Gabazza EC, Nishikawa M, Deguchi K, Shiku H.
    Clin Appl Thromb Hemost; 1999 Jan 15; 5(1):10-5. PubMed ID: 10725976
    [Abstract] [Full Text] [Related]

  • 14. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L, Blombäck M, Egberg N, Olsson A, Svane B, Velander M.
    Eur Heart J; 1997 Mar 15; 18(3):443-9. PubMed ID: 9076381
    [Abstract] [Full Text] [Related]

  • 15. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies.
    Farsi A, Domeneghetti MP, Brunelli T, Gori AM, Fedi S, Gensini GF, Giglioli C, Prisco D, Passaleva A, Meroni PL, Del Papa N, Abbate R.
    Atherosclerosis; 2001 Feb 01; 154(2):429-36. PubMed ID: 11166776
    [Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M.
    J Physiol Pharmacol; 2001 Aug 01; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [Abstract] [Full Text] [Related]

  • 17. Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.
    Prisco D, Fedi S, Antonucci E, Capanni M, Chiarugi L, Chioccioli M, Falai M, Giglioli C, Abbate R, Gensini GF.
    Thromb Res; 2001 Nov 01; 104(3):181-6. PubMed ID: 11672760
    [Abstract] [Full Text] [Related]

  • 18. Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses.
    Paparella D, Semeraro F, Scrascia G, Galeone A, Ammollo CT, Kounakis G, de Luca Tupputi Schinosa L, Semeraro N, Colucci M.
    Ann Thorac Surg; 2010 Feb 01; 89(2):421-7. PubMed ID: 20103314
    [Abstract] [Full Text] [Related]

  • 19. Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha2-antiplasmin complex is an independent predictor of coronary re-events.
    Redondo M, Carroll VA, Mauron T, Biasiutti FD, Binder BR, Lämmle B, Wuillemin WA.
    Blood Coagul Fibrinolysis; 2001 Jan 01; 12(1):17-24. PubMed ID: 11229822
    [Abstract] [Full Text] [Related]

  • 20. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
    Soeki T, Tamura Y, Fukuda N, Ito S.
    Jpn Circ J; 2000 Aug 01; 64(8):547-53. PubMed ID: 10952148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.